AIRNA

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of a ribonucleic acid (RNA) editing platform designed for healthcare professionals. AIRNA is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $339 million in Mar 2025. It has raised $245 million.

Last reported valuation
$339.0M
Oct 2026
Priced at
—
Total raised
$245.0M
Last round
—

Who backs AIRNA?

13 investors
InvestorType
Alexandria Venture InvestmentsOther
ARCH Venture PartnersVenture capital
VenrockVenture capital
ForbionVenture capital
RTW InvestmentsHedge fund
Novalis LifeSciencesAsset manager
Codon Capital—
Fast Track Initiative—
LifeLink Ventures—
ND Capital—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AIRNA investors

13 investors are on record for AIRNA, including Alexandria Venture Investments, ARCH Venture Partners, Venrock and Forbion. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 asset manager.

Free account
More of AIRNA with a free account
  • ·The complete investor list: 13 names
  • ·Watch AIRNA: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like AIRNA. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View